CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- 4 Open-market buy Director bought 1,000 shares at $10.12 ($10,115)
- 4/A Grant or award Chief Executive Officer acquired 353,450 shares (grant or award)
- 4/A Exercise or conversion Director acquired 30,000 shares (option exercise)
- 4/A Returned to the company Director returned 14,887 shares (to the company)
- 4 Conversion Director acquired 100,000 shares (conversion)
- 4 Grant or award Chief Medical Officer acquired 28,398 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 118,916 shares (grant or award)
- 4 Grant or award Director acquired 4,109,771 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 195,236 shares (grant or award)
- 4 Conversion Director acquired 30,000 shares (conversion)
- 4 Grant or award Chief Executive Officer acquired 353,450 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Conversion 10% owner acquired 40 shares (conversion)
- 4 Conversion 10% owner acquired 85,153 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 13 of 14 · 270 filings